Internal Medicine · Allen, TX
NPI
1316264971
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
931 State Hwy 121, Suite 4300
Allen, TX, 75013
Phone (469) 649-9995
Groups this clinician bills Medicare through
Medicare paid, 2024
$201K
2,554 services
Medicare patients, 2024
658
Average age 75
Drug cost, 2024
$2.6M
16,070 prescriptions
Company payments, 2025
$758
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Satish R Bagdure was code 99232 (hospital e&m - subsequent), 951 times for 409 patients. In total Satish R Bagdure billed 2,554 services in 17 codes, and Medicare paid $201K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 951 | 409 | $58.44 | $56K |
| 99222 Hospital E&M - Initial | Facility | 502 | 407 | $94.73 | $48K |
| 99233 Hospital E&M - Subsequent | Facility | 417 | 220 | $89.04 | $37K |
| 99239 Hospital Discharge Management | Facility | 257 | 219 | $85.00 | $22K |
| 99223 Hospital E&M - Initial | Facility | 182 | 155 | $127.30 | $23K |
| 99238 Hospital Discharge Management | Facility | 172 | 157 | $59.94 | $10K |
| 99231 Hospital E&M - Subsequent | Facility | 36 | 34 | $36.38 | $1,310 |
| 99221 Hospital E&M - Initial | Facility | 13 | 11 | $57.59 | $749 |
| 99291 Critical Care E&M | Facility | 12 | 11 | $157.82 | $1,894 |
By year: 2022 $157K for 2,253 services; 2023 $206K for 2,842 services; 2024 $201K for 2,554 services.
Medicare prescription drug claims, 2024
In 2024, the drug Satish R Bagdure prescribed most often to Medicare patients was Atorvastatin Calcium, with 571 prescriptions and refills. In total Satish R Bagdure wrote 16,070 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 571 | 1,326 | 185 | $5,802 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 555 | 557 | 123 | $11K |
| Losartan Potassium Generic | 475 | 1,102 | 133 | $4,124 |
| Gabapentin Generic | 384 | 724 | 125 | $6,847 |
| Potassium Chloride Generic | 378 | 686 | 123 | $5,010 |
| Pantoprazole Sodium Generic | 367 | 780 | 121 | $4,491 |
| Levothyroxine Sodium Generic | 326 | 805 | 103 | $2,478 |
| Mounjaro Tirzepatide | 273 | 287 | 46 | $303K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 265 | 276 | 73 | $6,482 |
| Furosemide Generic | 260 | 461 | 105 | $1,100 |
| Montelukast Sodium Generic | 240 | 468 | 78 | $1,921 |
| Amlodipine Besylate Generic | 239 | 587 | 85 | $1,517 |
| Eliquis Apixaban | 234 | 366 | 56 | $204K |
| Farxiga Dapagliflozin Propanediol | 212 | 390 | 60 | $219K |
| Tramadol Hcl Generic | 192 | 192 | 56 | $1,345 |
Brand drugs: 2,940 claims; generic drugs: 13,012 claims; opioid claims: 971.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Satish R Bagdure $758 ($758 in general payments such as food, travel and fees) from 16 companies. The largest payer was Sumitomo Pharma America, Inc. with $154.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 9 | $154 |
| Novo Nordisk Inc NVO | 5 | $111 |
| Pfizer Inc. PFE | 3 | $90.86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $67.12 |
| Alkermes, Inc. ALKS | 3 | $57.41 |
| Abbvie Inc. ABBV | 3 | $55.78 |
| Abbott Laboratories ABT | 2 | $46.36 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $30.58 |
| Gilead Sciences, Inc. GILD | 2 | $29.54 |
| Dexcom, Inc. DXCM | 1 | $22.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.